Tenascin-C orchestrates an immuno- suppressive tumor microenvironment with potential for targeting

被引：0
|
作者：
Loustau, T. [1 ]
Spenle, C. [1 ]
Murdamoothoo, D. [1 ]
Yilmaz, A. [1 ]
Orend, G. [1 ]
机构：
[1] Strasbourg Univ, INSERM, U1109, Strasbourg, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P178
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [41] Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
    Lingasamy, Prakash
    Tobi, Allan
    Haugas, Maarja
    Hunt, Hedi
    Paiste, Paarn
    Asser, Toomas
    Ratsep, Tonu
    Kotamraju, Venkata Ramana
    Bjerkvig, Rolf
    Teesalu, Tambet
    BIOMATERIALS, 2019, 219
  • [42] Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma
    Schliemann, Christoph
    Wiedmer, Andrea
    Pedretti, Marta
    Szczepanowski, Monika
    Klapper, Wolfram
    Neri, Dario
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1718 - 1722
  • [43] Paracrine role of glioma-secreted tenascin-C in tumor-induced angiogenesis
    Dictus, C.
    Vasvari, G.
    Unterberg, A. W.
    Herold-Mende, C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 322 - 323
  • [44] Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy
    Franz, Marcus
    Jung, Christian
    Lauten, Alexander
    Figulla, Hans R.
    Berndt, Alexander
    CELL ADHESION & MIGRATION, 2015, 9 (1-2) : 90 - 95
  • [45] Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential
    Galoian, Karine A.
    Garamszegi, Nandor
    Garamszegi, Susanna P.
    Scully, Sean P.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 232 (04) : 515 - 522
  • [46] Lessons from tenascin-C knockout mice and potential clinical application to subarachnoid hemorrhage
    Shiba, Masato
    Suzuki, Hidenori
    NEURAL REGENERATION RESEARCH, 2019, 14 (02) : 262 - 264
  • [47] Clinical Significance of Large Tenascin-C Spliced Variant as a Potential Biomarker for Colorectal Cancer
    Akihiko Takeda
    Yoshihide Otani
    Hiroyoshi Iseki
    Hideki Takeuchi
    Kimiyasu Aikawa
    Satoru Tabuchi
    Nozomi Shinozuka
    Toshiaki Saeki
    Yasushi Okazaki
    Isamu Koyama
    World Journal of Surgery, 2007, 31 : 388 - 394
  • [48] Amelioration of collagen antibody induced arthritis in mice by an antibody directed against the fibronectin type III repeats of tenascin-C Targeting fibronectin type III repeats of tenascin-C in rheumatoid arthritis
    Mehta, Brij Bhushan
    Tiwari, Anil
    Sharma, Saniya
    Shukla, Ashu
    Sharma, Maryada
    Vasishta, Rakesh K.
    Sen, Ramesh K.
    Sharma, Aman
    Luthra-Guptasarma, Manni
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 58 : 15 - 23
  • [49] Lessons from tenascin-C knockout mice and potential clinical application to subarachnoid hemorrhage
    Masato Shiba
    Hidenori Suzuki
    Neural Regeneration Research, 2019, 14 (02) : 262 - 264
  • [50] Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer
    Takeda, Akihiko
    Otani, Yoshihide
    Iseki, Hiroyoshi
    Takeuchi, Hideki
    Aikawa, Kimiyasu
    Tabuchi, Satoru
    Shinozuka, Nozomi
    Saeki, Toshiaki
    Okazaki, Yasushi
    Koyama, Isamu
    WORLD JOURNAL OF SURGERY, 2007, 31 (02) : 388 - 394
12345